LexaGene sells its MiQLab diagnostic testing system to Meridian Veterinary Capital in Dallas

LexaGene Holdings Inc (OTCQB:LXXGF) (CVE:LXG) (FRA:5XS2) announced that Meridian Veterinary Capital LLC in Dallas has purchased a MiQLab system.  The system will be used by the emergency and specialty veterinary hospitals that Meridian supports, with locations across the country. Meridian is a real estate investment and development firm that provides custom building solutions for animal health professionals.  “We continue to see traction in the veterinary market and expect this to build," said LexaGene CEO Dr Jack Regan in a statement. “Time and time again, we hear from our early adopters that the MiQLab boosts the confidence veterinarians have in making an initial diagnosis and prescribing the right therapy for any detected pathogen. Our customers love having a system in their own facility that can largely replace the need to send samples off-site to a reference laboratory where it takes days to get results back.”  READ: LexaGene says its MiQLab diagnostic testing system can detect the pathogen that causes plague Dr Regan added: “Our goal is that LexaGene will be recognized as the trusted, go-to-provider for veterinary in-clinic pathogen detection solutions.” MiQLab is an easy-to-use, sample-to-answer microbial detection system for a wide range of point-of-need applications. It provides fast, accurate, and reliable detection of up to 27 pathogens and antimicrobial resistance markers at once.  LexaGene said Meridian purchased a MiQLab to reduce the turnaround time for diagnostic testing so that the company’s veterinary partners can make evidence-based medical care decisions soon after seeing a sick pet. Veterinarians using MiQLab for in-clinic testing have increased confidence in prescribing the most appropriate antibiotic and keeping pet owners at ease knowing their loved ones are receiving the best possible care, the company said. “LexaGene’s MiQLab System is the start of a technology wave that is sweeping through veterinary care,” Dr Regan said. “We listened to our veterinary partners and developed the MiQLab System to help meet their point-of-care diagnostic needs. Fast and reliable diagnostic results translate into improved therapeutic treatments for our companion animals.” Contact the author: patrick@proactiveinvestors.com Follow him on Twitter @PatrickMGraham